Pinnacle Summer Investments’s Argos Therapeutics, Inc. ARGS Stock Holding History

Pinnacle Summer Investments’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$354K	Buy	7,662 +3,125	+69%	+$264K	0.05%	156
2015 Q3	$507K	Buy	4,537 +731	+19%	+$86.6K	0.09%	179
2015 Q2	$522K	Sell	3,806 -206	-5%	-$32.9K	0.11%	113
2015 Q1	$715K	Sell	4,012 -584	-13%	-$102K	0.1%	163
2014 Q4	$764K	Sell	4,596 -25	-0.5%	-$4.5K	0.09%	167
2014 Q3	$929K	Buy	4,621 +850	+23%	+$133K	0.1%	144
2014 Q2	$488K	Buy	3,771 +50	+1%	+$8.27K	0.06%	199
2014 Q1	$661K	Buy	+3,721	New	+$744K	0.08%	145

Other funds holding ARGS

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return

Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Pinnacle Summer Investments's ARGS Position: Q4 2015 in Review

Pinnacle Summer Investments increased its Argos Therapeutics, Inc. (ARGS) stake by 69% in Q4 2015, buying an estimated $264K and bringing the position to 7,662 shares worth $354K. The position accounts for 0.05% of the portfolio, ranked #156.

Pinnacle Summer Investments first reported a position in ARGS in Q1 2014 and has held it in 8 quarters since. The position peaked at $929K in Q3 2014. 25 funds tracked by Wall St. Rank hold ARGS as of Q4 2015.

Pinnacle Summer Investments held 7,662 shares of Argos Therapeutics, Inc. worth $354K as of Q4 2015.
Pinnacle Summer Investments bought 3,125 Argos Therapeutics, Inc. shares in Q4 2015, an estimated $264K.
Argos Therapeutics, Inc. made up 0.05% of Pinnacle Summer Investments's portfolio in Q4 2015, its #156 holding.
Pinnacle Summer Investments first reported a position in Argos Therapeutics, Inc. in Q1 2014 and has held it in 8 quarters since.
Pinnacle Summer Investments's Argos Therapeutics, Inc. position peaked at $929K in Q3 2014.
25 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.